PTMs of classical BC biomarkers can exert opposite effects on one biomarker, as in the case of TWIST1, when phosphorylation by MAPKs leads to its stabilization, invasiveness, EMT, and metastasis, while its phosphorylation by AKT1 is required for its ubiquitination and proteasomal degradation. The gene discussed is TWIST1; the disease is breast cancer.